Effect of dietary supplementation with glycitein during late pregnancy and lactation on antioxidative indices and performance of primiparous sows.

The objective of the present study was to investigate the effects of dietary supplementation with glycitein, a major soy isoflavone, during late pregnancy (starting on d 85) and lactation on antioxidative indices and performance in primiparous sows. A total of 227 gilts (Yorkshire × Landrace) were used, and after parturition, piglets were cross-fostered within treatment so that each sow suckled 10 piglets. Gilts were randomly divided into 4 groups on d 85 of pregnancy and thereafter fed the basal diets of gestation or lactation (controls) or those supplemented with 15, 30, or 45 mg/kg diet glycitein. Reproductive performance of the sows, growth of litters, concentration of plasma glycitein, milk composition, and antioxidative indices in sows' plasma and milk, such as the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), total antioxidant capacity (T-AOC), and the content of malondialdehyde (MDA), were measured. Supplementation of the dam's diets with glycitein increased ADG of piglets (linear, P = 0.003) and weaned BW of litters (linear, P = 0.01) and both variables were approximately 10% greater than controls with the 45 mg/kg treatment. The percentage of milk protein was linearly (P < 0.05) increased on d 1 and 7 of lactation, and milk fat content increased on d 7 and 14 (linear, P< 0.05). All other measured indices of performance were unaffected by supplementation with glycitein (P > 0.05). The glycitein concentration in sow's plasma was linearly (P < 0.0001) elevated. During lactation, linear increases occurred in plasma activities of SOD (P < 0.001) and T-AOC (P < 0.05 to P< 0.001), CAT (d 7 to 18 of lactation, P < 0.05) and GSH-Px (d 7 of lactation, P < 0.05), whereas the content of plasma MDA decreased (linear, P < 0.05) throughout lactation with glycitein supplementation. Activities of CAT and T-AOC in milk were not affected by maternal supplementation with glycitein, but increases in SOD on d 18 of lactation (P< 0.001) and GSH-Px in colostrum (P < 0.05) were observed. The content of MDA in milk was decreased (linear, P< 0.05) at all stages of lactation except d 14. Collectively, the results of this study indicate that dietary supplementation with glycitein in sows during late pregnancy and lactation elevated the antioxidative indices, decreased the content of MDA in sow's plasma and milk, improved milk composition, and enhanced the growth performance of the sucking piglets.

Supplemental phytases of microbial and cereal sources improve dietary phytate phosphorus utilization by pigs from weaning through finishing.

This experiment was conducted to measure the nutritional and metabolic responses of pigs fed diets with continuous supplementation of microbial and cereal phytase from weaning to finishing, and to determine the feasibility of complete replacement of inorganic P addition by supplemental phytase in swine diets. Forty-eight Landrace x Hampshire x Meishan pigs were divided into four groups. In phase 1 (10 to 50 kg BW), pigs in Groups 1, 2, 3, and 4 were fed a low-P, corn-soybean meal basal diet (BD), the BD plus microbial phytase (A. ficuum) at 1,200 units/kg, the BD plus 10% wheat bran (230 units of cereal phytase/kg), and the BD + .24% inorganic P (calcium phosphate), respectively. In phase 2 (51 to 90 kg BW), these pigs were fed a similar BD or the BD plus 1,000 microbial phytase units/kg, 20% wheat bran, or .20% inorganic P, respectively. Repeated measures included growth performance, P, Ca, and N balance, metatarsal and metacarpal bone strength, serum concentration of inorganic P, Ca, and 1,25-dihydroxycholecalciferol, and serum alkaline phosphatase activity. Pigs fed the BD supplemented with microbial phytase and pigs fed the BD supplemented with inorganic P showed almost identical responses for all variables. Pigs fed the BD supplemented with cereal phytase also had responses for various measures that were similar to those of pigs fed microbial phytase or inorganic P, except for some differences in serum inorganic P concentrations and bone strength in phase 1. Because of improvements in apparent digestibility of dietary P and N, fecal excretion of these two nutrients was reduced by 31 to 62% (P < .05) in pigs fed the BD supplemented with phytase compared with pigs fed inorganic P. It is physiologically feasible and environmentally advantageous to replace inorganic P with microbial or cereal phytase in corn-soybean meal diets for this type of pig through the entire growing-finishing period.

Treatment of postoperative gastric cancer with the Fuzheng Huoxue anticancer prescription.

AIM: To study effects of the Fuzheng Huoxue anticancer prescription (Traditional Chinese Medicine) in treatment of gastric cancer. METHODS: Sixty-nine patients with histologically confirmed mid- or late-stage gastric cancer were assigned to two groups. The treatment group included 35 cases (26 males and 9 females; 2 patients aged 33-40 years, 18 patients aged 41-60 years, and 15 patients aged 61-75 years; mean group age = 58.4 years). The control group included 34 cases (23 males and 11 females; 4 patients aged 33-40 years, 16 patients aged 41-60 years, and 14 patients aged 61-75 years; mean group age = 56.8 years. The two groups were not significantly different in sex, age, their clinical and pathological stages of disease or operation mode. The two groups of patients were given similar treatments; however, patients in the treatment group were given the Fuzheng Huoxue anticancer prescription. In animal studies, SGC-7901 gastric cancers cells were inoculated into the backs of 30 nude mice under sterile conditions. After inoculation, the nude mice were randomly allocated to a control group, a traditional Chinese medicine group, and a chemotherapy group (n = 10 mice per group). The total weight of the 10 mice in each group was similar. Each nude mouse in the control group received 0.5 mL of saline solution each day. Mice in the traditional Chinese medicine group received 0.5 mL of the Fuzheng Huoxue anticancer prescription (containing 1.5 g crude drug) each day, while mice in the chemotherapy group were intraperitoneally injected with 1 mg of 5-Fu once a week for 8 wk. RESULTS: Prior to treatment, the mean OKT8 percentage among gastric patients in the treatment group was 45.94% ± 8.45%, the mean OKT4/OKT8 ratio was 0.89 ± 0.19, the mean AT-III concentration was 29.9 ± 7.9 mg/dL, the mean Fa value was 50.4% ± 24.4%, and the mean ß-TG concentration was 91.0 ± 25.9 ng/dL. Prior to treatment, the mean percentage of OKT8 cells among patients in the control group was 49.21% ± 6.60%, the OKT4/OKT8 ratio was 0.94 ± 0.20, the AT-III concentration was 32.3 ± 7.2 mg/dL, the mean Fa value was 57.3% ± 24.6%, and the mean ß-TG concentration was 87.5 ± 34.2 ng/dL. After treatment, the mean OKT8 percentage among patients in the treatment group was 33.52% ± 7.80%, the mean OKT4/OKT8 ratio was 1.47 ± 0.51, the mean AT-III concentration was 38.8 ± 5.5 mg/dL, the mean Fa value was 102.6% ± 31.6%, and the mean ß-TG concentration was 62.3 ± 15.1 ng/dL. After treatment, the mean OKT8 percentage among patients in the control group was 42.22% ± 7.07%, the mean OKT4/OKT8 ratio was 1.12 ± 0.24, the mean AT-III concentration was 30.9 ± 8.0 mg/dL, the mean Fa value was 64.6% ± 26.9%, and the mean ß-TG concentration was 67.0 ± 42.1 ng/dL. These data indicate that after treatment, the immunologic function of the T lymphocytes of gastric cancer patients in the treatment group was significantly improved (P < 0.01). Additionally, the hypercoagulability in the treatment group was also improved (P < 0.001), and the mean OKT4/OKT8 ratio, antithrombin III (AT-III) concentration, and fibrinolytic activity, etc. had all beome normalized. The one-year (86%), 3-year (69%), and 5-year (40%) survival rates in the treatment group were all higher than those in the control group (P < 0.05). The mean tumor weights in the control, traditional medicine, and chemotherapy groups were 0.895 ± 0.289 g, 0.433 ± 0.177 g, and 0.357 ± 0.142 g, respectively. The tumor-inhibition rates in the traditional Chinese medicine group and chemotherapeutic group (51.6% and 60.1%, respectively) were significantly better than that in the control group (P < 0.001). The mean tumor weight in the traditional Chinese medicine group (24.68 ± 1.93 g) was significantly higher than that in both the treatment group (22.96 ± 1.87 g) and control group (22.47 ± 2.18 g). CONCLUSION: The Fuzheng Huoxue anticancer prescription can not only replenish vital functions (Zhengqi), correct a hypercoagulatory state, improve immunologic function, and extend patient survival times, but may also directly inhibit gastric tumor growth without producing toxic side effects.

[Clinical and experimental studies on treatment postoperative gastric cancer with combined therapy of fuzhen huoxue anticancer prescription and chemotherapy].

Fuzheng Huoxue Anticancer prescription (FZHXAC) showed better clinical effect in treating 35 cases of postoperative patients with gastric cancer in middle or late stage as compared with 35 cases of controls. After treatment, the immune function of T-lymphocytes enhanced significantly, the hypercoagulability improved, the criteria such as OKT4/OKT8 ratio, antithrombase III (AT-III), fibrinolytic activity, etc were all normalized, the one year, 3 year and 5 year suvival rate of patient were elevated. FZHXAC showed obvious inhibitory action on tumor growth in nude mice with transplanted human gastric cancer, as compared with control, the difference was significant, P < 0.001. In comparing with chemotherapeutic drug 5-fluorouracil, FZHXAC showed no significant toxicity, it didn't influence the normal growth of body weight. These results suggested that FZHXAC could not only replenish the Zheng-Qi, improve blood circulation, improve immune function and extend the survival period of patient, but also might have direct inhibiting, killing action on gastric tumor cells, this problem is expecting for further research.

[Pre-, post-operation and before death of blood stasis syndrome in patients with gastric malignant tumor].

In the past three years, the authors observed substance of tongue and 5 indexes of blood coagulation (AT-III, Fn, Fa, VIII R:Ag and beta TG) for a long time in 140 patients of gastric malignant tumor pre-operation, one month post-operation and 3 months before death. All patients were verified as gastric carcinoma by pathological section. The results showed that the positive rate of substance of tongue in patients pre-operation was as high as 58% (51/88), 5 indexes of blood coagulation in patients had obvious difference (P less than 0.001) comparing to that of healthy persons. This implied it existed relationship between gastric malignant tumor and blood stasis in TCM and accorded with diagnosis of blood stasis syndrome. With the resection of tumor focus, the states of blood stasis in patients had been improved to a certain extent. But the positive rate of substance of tongue post-operation was still as high as 51.1% (45/88) comparing to that pre-operation (P greater than 0.05), 5 indexes of blood coagulation in patients post-operation had no obvious improvement comparing to those pre-operation. This showed that the simple resection did not basically improve blood stasis in patients. The another important result was that the substance of tongue and 5 indexes of blood coagulation of 23 patients in last 3 months before death had more obvious blood stasis comparing to those post-operation even those pre-operation. This explained that blood stasis is one of the main characters of gastric malignant tumor before death. In conclusion, the extent of blood stasis syndrome can be used as an objective index to judge seriousness and prognosis of gastric malignant tumor patients' condition.